Wells Fargo Upgrades NuVasive (NUVA) to Outperform; Spine Market has Bottomed

June 21, 2012 7:38 AM EDT
Get Alerts NUVA Hot Sheet
Price: $54.96 +3.08%

Rating Summary:
    19 Buy, 15 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 5 | Down: 17 | New: 12
Trade NUVA Now!
Join SI Premium – FREE
Wells Fargo upgraded NuVasive (NASDAQ: NUVA) from Market Perform to Outperform, price target range raised from $17-18 to $29-31.

Analyst, Larry Biegelsen, said, "...we believe (1) the spine market has bottomed out; (2) NUVA's 2012 guidance and consensus appear overly conservative; (3) the possible elimination of the medical device tax represents significant upside potential to NUVA; and (4) valuation remains attractive.

For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.

Shares of NuVasive closed at $22.92 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Wells Fargo

Add Your Comment